Exosome Diagnostics
Matthew Dindinger is an experienced professional in the field of laboratory information management systems (LIMS) and automation. With a background in molecular biology and forensic science, Matthew has held various roles in companies such as Exosome Diagnostics, Courtagen Life Sciences, and Life Technologies. Matthew has expertise in NGS workflow, cancer genetics, genetic diseases, and forensic DNA analysis. Matthew has also supervised validation of robotics for automated DNA analysis procedures and conducted statistical analysis of DNA data. Matthew holds a BS in Molecular and Cell Biology, an MS in Forensic Science, and a BS in Information Technology.
This person is not in any offices
Exosome Diagnostics
Exosome Diagnostics is developing biofluid-based molecular diagnostic tests for use in personalized medicine. Exosomes and other microvesicles are shed into all biofluids, including blood, urine and cerebrospinal fluid, forming a highly enriched source of intact, disease-specific nucleic acids. The Company's proprietary exosome technologymakes use of this natural enrichment to achieve high sensitivity and specificity for rare gene transcripts and the expression of genes responsible for cancers and other diseases.